載入...
Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
Defects in antigen presenting cell function have been implicated in glioma immunosuppression. We measured peripheral CCL22, a dendritic cell/macrophage derived T cell trafficking chemokine, in sera from 1,208 glioma cases and 976 controls to assess whether it might provide a biomarker of glioma risk...
Na minha lista:
| 發表在: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4478165/ https://ncbi.nlm.nih.gov/pubmed/25604093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29441 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|